Polypill for Cardiovascular Disease Prevention in an Underserved Population | Zendy

Daniel Muñoz | Zendy; Prince Uzoije | Zendy; Cassandra Reynolds | Zendy; Roslynn Miller | Zendy; David Walkley | Zendy; Susan Pappalardo | Zendy; Phyllis M. Tousey | Zendy; Heather M. Munro | Zendy; Holly Gonzales | Zendy; WenLiang Song | Zendy; Charles S. White | Zendy; William J. Blot | Zendy; Thomas J. Wang | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Polypill for Cardiovascular Disease Prevention in an Underserved Population

Author(s) -

Daniel Muñoz,

Prince Uzoije,

Cassandra Reynolds,

Roslynn Miller,

David Walkley,

Susan Pappalardo,

Phyllis M. Tousey,

Heather M. Munro,

Holly Gonzales,

WenLiang Song,

Charles S. White,

William J. Blot,

Thomas J. Wang

Publication year - 2019

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1815359

Subject(s) - polypill , medicine , disease prevention , traditional medicine , environmental health , disease , population

Persons with low socioeconomic status and nonwhite persons in the United States have high rates of cardiovascular disease. The use of combination pills (also called "polypills") containing low doses of medications with proven benefits for the prevention of cardiovascular disease may be beneficial in such persons. However, few data are available regarding the use of polypill therapy in underserved communities in the United States, in which adherence to guideline-based care is generally low.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research